Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Conor C Lynch

Showing results (41-50 of 66) with videos related to

Pageof 7
Sort By:
International Journal of Cancer|June 30, 2020
Histone deacetylase inhibition prevents the growth of primary and metastatic osteosarcomaJeremy J McGuire, Niveditha Nerlakanti, Chen Hao Lo, et al.
Clinical & Experimental Metastasis|December 1, 2006
The application of a murine bone bioreactor as a model of tumor: bone interactionJennifer Halpern, Conor C Lynch, Jonathan Fleming, et al.
Plos One|January 19, 2012
An MMP13-selective inhibitor delays primary tumor growth and the onset of tumor-associated osteolytic lesions in experimental models of breast cancerManisha Shah, Dexing Huang, Tony Blick, et al.
Oncogene|August 15, 2019
Betaglycan drives the mesenchymal stromal cell osteogenic program and prostate cancer-induced osteogenesisLeah M Cook, Jeremy S Frieling, Niveditha Nerlakanti, et al.
Scientific Reports|November 26, 2015
Identification of Synergistic, Clinically Achievable, Combination Therapies for OsteosarcomaDiana Yu, Elliot Kahen, Christopher L Cubitt, et al.
Cancer Research|August 5, 2008
Effect of ablation or inhibition of stromal matrix metalloproteinase-9 on lung metastasis in a breast cancer model is dependent on genetic backgroundMichelle D Martin, Kathy J Carter, Sharon R Jean-Philippe, et al.
Cancer Research|December 3, 2008
Metastasis Research Society-American Association For Cancer Research Joint Conference on MetastasisDanny R Welch, Carlton R Cooper, Douglas R Hurst, et al.
Nature Communications|February 2, 2021
Mesenchymal stem cell-derived interleukin-28 drives the selection of apoptosis resistant bone metastatic prostate cancerJeremy J McGuire, Jeremy S Frieling, Chen Hao Lo, et al.
Clinical & Experimental Metastasis|September 1, 2014
Improving treatment strategies for patients with metastatic castrate resistant prostate cancer through personalized computational modelingJill Gallaher, Leah M Cook, Shilpa Gupta, et al.
Cancer Research|October 17, 2025
PRDM16 Regulates Prostate Cancer Cell Dormancy and Prevents Bone Metastatic OutgrowthMostafa M Nasr, Bishoy Wadie, Tao Li, et al.
Pageof 7

Showing results (41-50 of 66) with videos related to

Sort By:
Pageof 7
International Journal of Cancer|June 30, 2020
Histone deacetylase inhibition prevents the growth of primary and metastatic osteosarcomaJeremy J McGuire, Niveditha Nerlakanti, Chen Hao Lo, et al.
Clinical & Experimental Metastasis|December 1, 2006
The application of a murine bone bioreactor as a model of tumor: bone interactionJennifer Halpern, Conor C Lynch, Jonathan Fleming, et al.
Plos One|January 19, 2012
An MMP13-selective inhibitor delays primary tumor growth and the onset of tumor-associated osteolytic lesions in experimental models of breast cancerManisha Shah, Dexing Huang, Tony Blick, et al.
Oncogene|August 15, 2019
Betaglycan drives the mesenchymal stromal cell osteogenic program and prostate cancer-induced osteogenesisLeah M Cook, Jeremy S Frieling, Niveditha Nerlakanti, et al.
Scientific Reports|November 26, 2015
Identification of Synergistic, Clinically Achievable, Combination Therapies for OsteosarcomaDiana Yu, Elliot Kahen, Christopher L Cubitt, et al.
Cancer Research|August 5, 2008
Effect of ablation or inhibition of stromal matrix metalloproteinase-9 on lung metastasis in a breast cancer model is dependent on genetic backgroundMichelle D Martin, Kathy J Carter, Sharon R Jean-Philippe, et al.
Cancer Research|December 3, 2008
Metastasis Research Society-American Association For Cancer Research Joint Conference on MetastasisDanny R Welch, Carlton R Cooper, Douglas R Hurst, et al.
Nature Communications|February 2, 2021
Mesenchymal stem cell-derived interleukin-28 drives the selection of apoptosis resistant bone metastatic prostate cancerJeremy J McGuire, Jeremy S Frieling, Chen Hao Lo, et al.
Clinical & Experimental Metastasis|September 1, 2014
Improving treatment strategies for patients with metastatic castrate resistant prostate cancer through personalized computational modelingJill Gallaher, Leah M Cook, Shilpa Gupta, et al.
Cancer Research|October 17, 2025
PRDM16 Regulates Prostate Cancer Cell Dormancy and Prevents Bone Metastatic OutgrowthMostafa M Nasr, Bishoy Wadie, Tao Li, et al.
Pageof 7